Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it contrast to its rivals? We will compare Cytek Biosciences to similar businesses based on the strength of its analyst recommendations, earnings, valuation, dividends, profitability, institutional ownership and risk. Analyst Ratings This is a summary […]